Watch POAP mints live!

over 2 years ago

Loading

I completed the DS&AI Event Survey!

Thanks for for taking the time to complete this survey, It was a pleasure seeing you in Madrid!

almost 3 years ago

I completed the DS&AI Event Survey! POAP image

almost 3 years ago

Loading

I've met Roberta at Bayer DS&AI event

I am a pharmacist from Rio de Janeiro-Brazil and I work as a computational chemist at Bayer since 2021 in the Computational Molecular Design department in Wuppertal. I work side by side with chemists on different projects using our digital tools to design small molecules that maybe one day will help patients! I am passionate about my work and I have the opportunity to also be part of the Steering Group for Transformation and Leadership in the Drug Discovery Science to help transforming the way we work and communicate.

almost 3 years ago

I've met Roberta at Bayer DS&AI event POAP image

I've met Lily Wong at Bayer's Global DS&AI F2F Meeting

Experienced leader in development, validation, and implementation of clinical trial software and processes

almost 3 years ago

I've met Lily Wong at Bayer's Global DS&AI F2F Meeting POAP image

almost 3 years ago

Loading

The Data Assets and Insights Solutions subfunction, DAIS, consists of a team of dedicated computer and data scientists which combine deep R&D process and domain expertise (biology, chemistry, pharmacy, etc) with advanced computational expertise (software engineering, natural language processing, scalable architectures, bio- & chem-informatics, data integration & visualization, etc). We integrate, enrich and harmonize large scientific datasets to build foundational data assets which are used by the R&D organization and our team to build insights solutions. They address key R&D challenges to improve speed, quality and probability of success of our R&D pipeline. Selected business critical tasks within R&D we are focusing on: - Target identification including holistic assessment - Disease understanding including precision medicine - Pipeline evaluation (therapeutic potential and risks) - Modality selection including identification of tool compounds - Identification of collaboration and in-licensing opportunities For more information contact: Wolfgang Thielemann. Artwork: Licensed pictures.

almost 3 years ago

I was at the Bayer DS&AI Poster - Data Assets and Insights Solutions POAP image

almost 3 years ago

Loading

almost 3 years ago

Loading

almost 3 years ago

Loading